Zeo ScientifiX Inc (ZEOX)

[Buellersback]

New tweet!: We’re pleased to share we have received Orphan Drug Designation from the European Medicines Agency, for QIXLEEF™, as a potential treatment for Complex Regional Pain Syndrome, a chronic neuropathic pain condition. $TBP $TBPMF

We’re pleased to share we have received Orphan Drug Designation from the European Medicines Agency, for QIXLEEF™, as a potential treatment for Complex Regional Pain Syndrome, a chronic neuropathic pain condition. $TBP $TBPMF pic.twitter.com/04vTyDGW3A

— Tetra Bio-Pharma (@TetraBioPharma) November 16, 2021